Adenovirus infection after allogeneic stem cell transplantation

References

• Handgretinger R, Lang P, Schumm M, Pfeiffer M, Gottschling S, Demirdelen B, Bader P, et al. Immunological aspects of haploidentical stem cell transplantation in children. Ann NY Acad Sci 2001; 938: 340–357
   PubMed Web of Science ®Google Scholar
• Lang P, Handgretinger R, Niethammer D, Schlegel P G, Schumm M, Greil J, Bader P, et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 2003; 101: 1630–1636
   PubMed Web of Science ®Google Scholar
• Lewin S R, Heller G, Zhang L, Rodrigues E, Skulsky E, van den Brink M R, Small T N, et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 2002; 100: 2235–2242
   PubMed Web of Science ®Google Scholar
• Bahceci E, Epperson D, Douek D C, Melenhorst J J, Childs R C, Barrett A J. Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism. Br J Haematol 2003; 122: 934–943
   PubMed Web of Science ®Google Scholar
• Mohty M, Jacot W, Faucher C, Bay J O, Zandotti C, Collet L, Choufi B, et al. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia 2003; 17: 2168–2177
   PubMed Web of Science ®Google Scholar
• Lion T, Baumgartinger R, Watzinger F, Matthes-Martin S, Suda M, Preuner S, Futterknecht B, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003; 102: 1114–1120
   PubMed Web of Science ®Google Scholar
• Walls T, Shankar A G, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 2003; 3: 79–86
   PubMed Web of Science ®Google Scholar
• Flomenberg P, Babbitt J, Drobyski W R, Ash R C, Carrigan D R, Sedmak G V, McAuliffe T, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775–781
   PubMed Web of Science ®Google Scholar
• Shirali G S, Ni J, Chinnock R E, Johnston J K, Rosenthal G L, Bowles N E, Towbin J A, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001; 344: 1498–1503
   PubMed Web of Science ®Google Scholar
• Kojaoghlanian T, Flomenberg P, Horwitz M S. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 2003; 13: 155–171
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Mautner V, Osman H, Collingham K E, Fegan C D, Klapper P E, Moss P A, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619–1627
   PubMed Web of Science ®Google Scholar
• Feuchtinger T, Lucke J, Hamprecht K, Richard C, Handgretinger R, Schumm M, Greil J, et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005; 128: 503–509
   PubMed Web of Science ®Google Scholar
• Heemskerk B, Lankester A C, van Vreeswijk T, Beersma M F, Claas E C, Veltrop-Duits L A, Kroes A C, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 2005; 191: 520–530
   PubMed Web of Science ®Google Scholar
• Shields A F, Hackman R C, Fife K H, Corey L, Meyers J D. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529–533
   PubMed Web of Science ®Google Scholar
• Bruno B, Zager R A, Boeckh M J, Gooley T A, Myerson D H, Huang M L, Hackman R C. Adenovirus nephritis in hematopoietic stem-cell transplantation. Transplantation 2004; 77: 1049–1057
   PubMed Web of Science ®Google Scholar
• Davison A J, Benko M, Harrach B. Genetic content and evolution of adenoviruses. J Gen Virol 2003; 84(Pt 11)2895–2908
   PubMed Web of Science ®Google Scholar
• Russell W C. Update on adenovirus and its vectors. J Gen Virol 2000; 81(Pt 11)2573–2604
   PubMed Web of Science ®Google Scholar
• Bergelson J M, Cunningham J A, Droguett G, Kurt-Jones E A, Krithivas A, Hong J S, Horwitz M S, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320–1323
   PubMed Web of Science ®Google Scholar
• Gaggar A, Shayakhmetov D M, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408–1412
   PubMed Web of Science ®Google Scholar
• Amberg N, Edlund K, Kidd A H, Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol 2000; 74: 42–48
   PubMed Web of Science ®Google Scholar
• Shayakhmetov D M, Li Z Y, Ternovoi V, Gaggar A, Gharwan H, Lieber A. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol 2003; 77: 3712–3723
   PubMed Web of Science ®Google Scholar
• Leopold P L, Kreitzer G, Miyazawa N, Rempel S, Pfister K K, Rodriguez-Boulan E, Crystal R G. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther 2000; 11: 151–165
   PubMed Web of Science ®Google Scholar
• Schmitz H, Wigand R, Heinrich W. Worldwide epidemiology of human adenovirus infections. Am J Epidemiol 1983; 117: 455–466
   PubMed Web of Science ®Google Scholar
• Flomenberg P, Piaskowski V, Truitt R L, Casper J T. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis 1995; 171: 1090–1096
   PubMed Web of Science ®Google Scholar
• Sester M, Sester U, Salvador S A, Heine G, Lipfert S, Girndt M, Gartner B, et al. Age-related decrease in adenovirus-specific T cell responses. J Infect Dis 2002; 185: 1379–1387
   PubMed Web of Science ®Google Scholar
• Adrian T, Schafer G, Cooney M K, Fox J P, Wigand R. Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect 1988; 101: 503–509
   PubMed Web of Science ®Google Scholar
• Fox J P, Brandt C D, Wassermann F E, Hall C E, Spigland I, Kogon A, Elveback L R. The Virus Watch Program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol 1969; 89: 25–50
   PubMed Web of Science ®Google Scholar
• Fox J P, Hall C E, Cooney M K. The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol 1977; 105: 362–386
   PubMed Web of Science ®Google Scholar
• Garnett C T, Erdman D, Xu W, Gooding L R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002; 76: 10608–10616
   PubMed Web of Science ®Google Scholar
• Wold W S, Doronin K, Toth K, Kuppuswamy M, Lichtenstein D L, Tollefson A E. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr Opin Immunol 1999; 11: 380–386
   PubMed Web of Science ®Google Scholar
• Flomenberg P, Piaskowski V, Truitt R L, Casper J T. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol 1996; 70: 6314–6322
   PubMed Web of Science ®Google Scholar
• Wold W S, Gooding L R. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol Biol Med 1989; 6: 433–452
   PubMedGoogle Scholar
• Wold W S, Gooding L R. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991; 184: 1–8
   PubMedGoogle Scholar
• Cotter M J, Zaiss A K, Muruve D A. Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J Virol 2005; 79: 14622–14631
   PubMed Web of Science ®Google Scholar
• Liu Z X, Govindarajan S, Okamoto S, Dennert G. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 2000; 164: 6480–6486
   PubMed Web of Science ®Google Scholar
• Ruzek M C, Kavanagh B F, Scaria A, Richards S M, Garman R D. Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression. Mol Ther 2002; 5: 115–124
   PubMed Web of Science ®Google Scholar
• Lang P, Griesinger A, Hamprecht K, Feuchtinger T, Schumm M, Neuhauser F, Greil J, et al. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors. Hum Immunol 2004; 65: 423–431
   PubMed Web of Science ®Google Scholar
• Callan M F, Tan L, Annels N, Ogg G S, Wilson J D, O'Callaghan C A, Steven N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998; 187: 1395–1402
   PubMed Web of Science ®Google Scholar
• Callan M F, Steven N, Krausa P, Wilson J D, Moss P A, Gillespie G M, Bell J I, et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996; 2: 906–911
   PubMed Web of Science ®Google Scholar
• Butz E A, Bevan M J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998; 8: 167–175
   PubMed Web of Science ®Google Scholar
• Molinier-Frenkel V, Gahery-Segard H, Mehtali M, Le Boulaire C, Ribault S, Boulanger P, Tursz T, et al. Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol 2000; 74: 7678–7682
   PubMed Web of Science ®Google Scholar
• Smith C A, Woodruff L S, Kitchingman G R, Rooney C M. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J Virol 1996; 70: 6733–6740
   PubMed Web of Science ®Google Scholar
• Smith C A, Woodruff L S, Rooney C, Kitchingman G R. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum Gene Ther 1998; 9: 1419–1427
   PubMed Web of Science ®Google Scholar
• Heemskerk B, Veltrop-Duits L A, van Vreeswijk T, ten Dam M M, Heidt S, Toes R E, van Tol M J, et al. Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol 2003; 77: 6562–6566
   PubMed Web of Science ®Google Scholar
• Molinier-Frenkel V, Lengagne R, Gaden F, Hong S S, Choppin J, Gahery-Segard H, Boulanger P, et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol 2002; 76: 127–135
   PubMed Web of Science ®Google Scholar
• Rux J J, Kuser P R, Burnett R M. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 2003; 77: 9553–9566
   PubMed Web of Science ®Google Scholar
• Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther 2002; 13: 1167–1178
   PubMedGoogle Scholar
• Tang J, Olive M, Champagne K, Flomenberg N, Eisenlohr L, Hsu S, Flomenberg P. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther 2004; 11: 1408–1415
   PubMed Web of Science ®Google Scholar
• Leen A M, Sili U, Vanin E F, Jewell A M, Xie W, Vignali D, Piedra P A, et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 2004; 104: 2432–2440
   PubMed Web of Science ®Google Scholar
• Bicanic O, Richard C, Stevanovic S, Lang P, Wernet K, Hamprecht K, Schumm M, et al. Analysis of the adenovirus specific T-cell response, using MHC-I peptides of the adenoviral hexon-protein for the detection and isolation of specific T-cells. Bone Marrow Transplant 2005; 35: S25
   PubMed Web of Science ®Google Scholar
• Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K, Schaefer U W, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51–57
   PubMed Web of Science ®Google Scholar
• Howard D S, Phillips G L, II, Reece D E, Munn R K, Henslee-Downey J, Pittard M, Barker M. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999; 29: 1494–1501
   PubMed Web of Science ®Google Scholar
• Baldwin A, Kingman H, Darville M, Foot A B, Grier D, Cornish J M, Goulden N, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333–1338
   PubMed Web of Science ®Google Scholar
• van Tol M J, Kroes A C, Schinkel J, Dinkelaar W, Claas E C, Jol-van der Zijde C M, Vossen J M. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 2005; 36: 39–50
   PubMed Web of Science ®Google Scholar
• La Rosa A M, Champlin R E, Mirza N, Gajewski J, Giralt S, Rolston K V, Raad I, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871–876
   PubMed Web of Science ®Google Scholar
• Bruno B, Boeck M, Davis C, Gooley T, Hackman R C. Adenovirus infections in patients undergoing bone marrow transplantation. Blood (Suppl.) 1997; 1867a
   Google Scholar
• Hale G A, Heslop H E, Krance R A, Brenner M A, Jayawardene D, Srivastava D K, Patrick C C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999; 23: 277–282
   PubMed Web of Science ®Google Scholar
• Myers G D, Krance R A, Weiss H, Kuehnle I, Demmler G, Heslop H E, Bollard C M. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant 2005; 36: 1001–1008
   PubMed Web of Science ®Google Scholar
• Echavarria M, Forman M, van Tol M J, Vossen J M, Charache P, Kroes A C. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001; 358: 384–385
   PubMed Web of Science ®Google Scholar
• Schilham M W, Claas E C, van Zaane W, Heemskerk B, Vossen J M, Lankester A C, Toes R E, et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002; 35: 526–532
   PubMed Web of Science ®Google Scholar
• Kampmann B, Cubitt D, Walls T, Naik P, Depala M, Samarasinghe S, Robson D, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005; 130: 595–603
   PubMed Web of Science ®Google Scholar
• Bredius R G, Templeton K E, Scheltinga S A, Claas E C, Kroes A C, Vossen J M. Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Pediatr Infect Dis J 2004; 23: 518–522
   PubMed Web of Science ®Google Scholar
• Allard A, Girones R, Juto P, Wadell G. Polymerase chain reaction for detection of adenoviruses in stool samples. J Clin Microbiol 1990; 28: 2659–2667
   PubMed Web of Science ®Google Scholar
• Pring-Akerblom P, Adrian T. Type- and group-specific polymerase chain reaction for adenovirus detection. Res Virol 1994; 145: 25–35
   PubMedGoogle Scholar
• Pring-Akerblom P, Adrian T, Kostler T. PCR-based detection and typing of human adenoviruses in clinical samples. Res Virol 1997; 148: 225–231
   PubMedGoogle Scholar
• Echavarria M, Forman M, Ticehurst J, Dumler J S, Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol 1998; 36: 3323–3326
   PubMed Web of Science ®Google Scholar
• Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003; 70: 228–239
   PubMed Web of Science ®Google Scholar
• Claas E C, Schilham M W, de Brouwer C S, Hubacek P, Echavarria M, Lankester A C, van Tol M J, et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005; 43: 1738–1744
   PubMed Web of Science ®Google Scholar
• Lankester A C, van Tol M J, Claas E C, Vossen J M, Kroes A C. Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis 2002; 34: 864–867
   PubMed Web of Science ®Google Scholar
• Ebner K, Suda M, Watzinger F, Lion T. Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J Clin Microbiol 2005; 43: 3049–3053
   PubMed Web of Science ®Google Scholar
• Ko G, Cromeans T L, Sobsey M D. Detection of infectious adenovirus in cell culture by mRNA reverse transcription-PCR. Appl Environ Microbiol 2003; 69: 7377–7384
   PubMed Web of Science ®Google Scholar
• Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P, Bierings M, et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 2005; 10: 225–229
   PubMed Web of Science ®Google Scholar
• Stock R, Harste G, Madisch I, Heim A. A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity. Antiviral Res 2006; 72: 34–41
   PubMed Web of Science ®Google Scholar
• Malasig M D, Goswami P R, Crawford-Miksza L K, Schnurr D P, Gray G C. Simplified microneutralization test for serotyping adenovirus isolates. J Clin Microbiol 2001; 39: 2984–2986
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Itoh N, Uchio E, Aoki K, Ohno S. Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol 1999; 37: 1839–1845
   PubMed Web of Science ®Google Scholar
• Allard A, Albinsson B, Wadell G. Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis. J Clin Microbiol 2001; 39: 498–505
   PubMed Web of Science ®Google Scholar
• Walls T, Hawrami K, Ushiro-Lumb I, Shingadia D, Saha V, Shankar A G. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?. Clin Infect Dis 2005; 40: 1244–1249
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Collingham K E, Stevens R H, Pillay D, Fegan C D, Milligan D W. Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study. Bone Marrow Transplant 2000; 25: 277–282
   PubMed Web of Science ®Google Scholar
• Hierholzer J C. Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992; 5: 262–274
   PubMed Web of Science ®Google Scholar
• Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C, van Rhee F, et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998; 22: 889–893
   PubMed Web of Science ®Google Scholar
• Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori S, Ohashi K, Tanikawa S, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325–1330
   PubMed Web of Science ®Google Scholar
• Mori K, Yoshihara T, Nishimura Y, Uchida M, Katsura K, Kawase Y, Hatano I, et al. Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient. Bone Marrow Transplant 2003; 31: 1173–1176
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Collingham K E, Fegan C D, Milligan D W. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant 1999; 23: 1209–1211
   PubMed Web of Science ®Google Scholar
• Johnson P R, Yin J A, Morris D J, Desai M, Cinkotai K I, McKeogh M M. Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation. Bone Marrow Transplant 1990; 5: 345–347
   PubMed Web of Science ®Google Scholar
• Kinchington P R, Romanowski E G, Jerold G Y. Prospects for adenovirus antivirals. J Antimicrob Chemother 2005; 55: 424–429
   PubMed Web of Science ®Google Scholar
• Leruez-Ville M, Minard V, Lacaille F, Buzyn A, Abachin E, Blanche S, Freymuth F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004; 38: 45–52
   PubMed Web of Science ®Google Scholar
• Muller W J, Levin M J, Shin Y K, Robinson C, Quinones R, Malcolm J, Hild E, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis 2005; 41: 1812–1816
   PubMed Web of Science ®Google Scholar
• Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M, Machaczka M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 481–486
   PubMed Web of Science ®Google Scholar
• Bordigoni P, Carret A S, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32: 1290–1297
   PubMedGoogle Scholar
• Legrand F, Berrebi D, Houhou N, Freymuth F, Faye A, Duval M, Mougenot J F, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621–626
   PubMed Web of Science ®Google Scholar
• Hoffman J A, Shah A J, Ross L A, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388–394
   PubMed Web of Science ®Google Scholar
• Yusuf U, Hale G A, Carr J, Gu Z, Benaim E, Woodard P, Kasow K A, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81: 1398–1404
   PubMed Web of Science ®Google Scholar
• Liles W C, Cushing H, Holt S, Bryan C, Hackman R C. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant 1993; 12: 409–412
   PubMed Web of Science ®Google Scholar
• Jurado M, Navarro J M, Hernandez J, Molina M A, DePablos J M. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplant 1995; 15: 651–652
   PubMed Web of Science ®Google Scholar
• Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M, Saito H, et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 2000; 25: 545–548
   PubMed Web of Science ®Google Scholar
• Shetty A K, Gans H A, So S, Millan M T, Arvin A M, Gutierrez K M. Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000; 29: 69–73
   PubMed Web of Science ®Google Scholar
• Gavin P J, Katz B Z. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002; 110(1 Pt 1)e9
   PubMed Web of Science ®Google Scholar
• Lankester A C, Heemskerk B, Claas E C, Schilham M W, Beersma M F, Bredius R G, van Tol M J, et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis 2004; 38: 1521–1525
   PubMed Web of Science ®Google Scholar
• Greil J, Bader P, Lang P, Beck R, Feuchtinger T, Niethammer D. Prophylactic ribavirin treatment prevents adenovirus infection in pediatric stem cell transplant recipients. Blood (Suppl) 2003; 102: 449B
   PubMed Web of Science ®Google Scholar
• Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, Handgretinger R, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134: 64–76
   PubMed Web of Science ®Google Scholar
• Rooney C M, Smith C A, Ng C Y, Loftin S K, Sixbey J W, Gan Y, Srivastava D K, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549–1555
   PubMed Web of Science ®Google Scholar
• Walter E A, Greenberg P D, Gilbert M J, Finch R J, Watanabe K S, Thomas E D, Riddell S R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038–1044
   PubMed Web of Science ®Google Scholar
• Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, Loffler J, Grigoleit U, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002; 99: 3916–3922
   PubMed Web of Science ®Google Scholar
• Riddell S R, Watanabe K S, Goodrich J M, Li C R, Agha M E, Greenberg P D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992; 257: 238–241
   PubMed Web of Science ®Google Scholar
• Sun J C, Williams M A, Bevan M J. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 2004; 5: 927–933
   PubMed Web of Science ®Google Scholar
• Bevan M J. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004; 4: 595–602
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Collingham K E, Fegan C D, Pillay D, Milligan D W. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?. Bone Marrow Transplant 2000; 26: 305–307
   PubMed Web of Science ®Google Scholar
• Hromas R, Cornetta K, Srour E, Blanke C, Broun E R. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994; 84: 1689–1690
   PubMed Web of Science ®Google Scholar
• Moss P, Rickinson A. Cellular immunotherapy for viral infection after HSC transplantation. Nat Rev Immunol 2005; 5: 9–20
   PubMed Web of Science ®Google Scholar
• Leen A M, Rooney C M. Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol 2005; 128: 135–144
   PubMed Web of Science ®Google Scholar
• Feuchtinger T, Lang P, Hamprecht K, Schumm M, Greil J, Jahn G, Niethammer D, et al. Isolation And Expansion Of Human Adenovirus Specific CD4+ And CD8+ T-cells According To IFN-gamma Secretion For Adjuvant Immunotherapy. Exp Hematol 2004; 32: 282–289
   PubMed Web of Science ®Google Scholar